Safety of New Phosphate Binders for Chronic Renal Failure

ISSN： 0114-5916

Source： Drug Safety, Vol.26, Iss.15, 2003-01, pp. : 1093-1115

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles

By Locatelli Francesco Del Vecchio Lucia Violo Leano Pontoriero Giuseppe

Expert Opinion on Drug Safety, Vol. 13, Iss. 5, 2014-05 ,pp. : 551-561

Informa Healthcare

Access to resources Recommend Favorite

Optimal use of phosphate binders in chronic kidney disease

By Sonikian Makrouhi Papachristou Evangelos Goumenos Dimitrios S

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 18, 2013-12 ,pp. : 2521-2532

Informa Healthcare

Access to resources Recommend Favorite

Lanthanum Carbonate - A New Phosphate Binding Drug in Advanced Renal Failure

Current Medicinal Chemistry, Vol. 25, Iss. 1, 2018-01 ,pp. : 113-117

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Metabolism in Chronic Renal Failure

Current Drug Metabolism, Vol. 4, Iss. 2, 2003-04 ,pp. : 91-103

Bentham Science Publishers

Access to resources Recommend Favorite

Sodium phosphate: Renal failure and nephrocalcinosis: case report

Reactions Weekly, Vol. 1, Iss. 1092, 2006-01 ,pp. : 23-24

Adis International

Access to resources Recommend Favorite